Are quantum dots ready for in vivo imaging in human subjects?
about
Pharmacokinetic issues of imaging with nanoparticles: focusing on carbon nanotubes and quantum dotsComparison of Toxicity of CdSe: ZnS Quantum Dots on Male Reproductive System in Different Stages of Development in MiceLow concentration of silver nanoparticles not only enhances the activity of horseradish peroxidase but alter the structure alsoCurrent applications and future prospects of nanomaterials in tumor therapyPhotoacoustic imaging.Molecular Imaging with Single-Walled Carbon Nanotubes.Multimodality molecular imaging of CD105 (Endoglin) expression.Structure and dysprosium dopant engineering of gadolinium oxide nanoparticles for enhanced dual-modal magnetic resonance and fluorescence imaging.In vivo imaging of RNA interference.Real-time multi-parameter spectroscopy and localization in three-dimensional single-particle tracking.Peptide-based probes for targeted molecular imaging.Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging.Non-invasive imaging of human embryonic stem cells.Location deterministic biosensing from quantum-dot-nanowire assembliesCancer-targeted optical imaging with fluorescent zinc oxide nanowires.In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesisTumor-targeted drug delivery with aptamersPositron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody.Effective cellular internalization of silica-coated CdSe quantum dots for high contrast cancer imaging and labelling applicationsGraphene: a versatile nanoplatform for biomedical applications.ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CW.In a "nutshell": intrinsically radio-labeled quantum dots.Molecular imaging of insulin-like growth factor 1 receptor in cancer.In vivo molecular imaging using nanomaterials: general in vivo characteristics of nano-sized reagents and applications for cancer diagnosis.Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW.Near-infrared quantum dots as optical probes for tumor imaging.Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseasesApplications of gold nanoparticles in cancer nanotechnology.Long-term persistence and spectral blue shifting of quantum dots in vivo.Quantum dot-based nanoprobes for in vivo targeted imaging.Biomedical applications of zinc oxide nanomaterials.Molecular imaging and therapy of cancer with radiolabeled nanoparticles.Intraoperative targeted optical imaging: a guide towards tumor-free margins in cancer surgery.Near infrared imaging with nanoparticles.Molecular Imaging of Proteases in Cancer.Non-invasive cell tracking in cancer and cancer therapy.Imaging with Raman spectroscopy.Protease sensing with nanoparticle based platforms.Multimodality Imaging of Integrin α(v)β(3) Expression.Molecular imaging with nucleic acid aptamers.
P2860
Q28388580-2B49B0D2-5968-4CA6-B87C-671133C800B5Q28389784-F32145F9-38D9-4A11-87FD-02FF526D79A8Q28481636-397C1F41-3BE3-473B-9765-7B76C2BA347FQ29248618-E26EF54A-0FE3-4307-8E4A-069D9FDA2931Q30430595-642E69C7-BEFF-44BC-A87E-BFE3E3632617Q30474862-2198D3CA-B031-4B93-BEC2-F843502E87A5Q30476445-E13AED05-EEBA-4059-BB85-2D309CE807A2Q31159248-17183339-F076-4C43-99E6-5D9C9D4BFAB8Q33348480-1F19DC23-940F-44A9-B04E-5EB7D893D36BQ33364352-2CA12812-8AD5-490F-85FC-542DDE19DD00Q33526620-5B87742A-1B77-47B3-AD69-3D61D641A4A8Q33815079-94D0677E-220F-4160-ABE8-2F917EAA036CQ34050057-71EA4787-CD57-4411-91D2-C6D070FD9E89Q34296125-8CC94C53-6216-4485-BC22-1DCCA5FB5BBEQ35214391-AADC6F0E-608B-4FCF-8A46-0F74309095DEQ35291271-60DF65E2-A64A-449D-85D2-852F2E8B6F49Q35490874-5B580803-CA24-4830-B975-C33BE7796BC4Q35809541-705EC13E-3C55-4C19-8C52-440294F9935AQ35839626-FBC49FBD-F216-4F98-B28A-0766DD43D86CQ36035392-B9EEB646-82BD-4E67-8400-BBBCC27AFD34Q36185354-2BC3E317-5839-423F-B42D-F236764A60DDQ36337263-02ABF1DA-93A0-4610-9715-E29D80F31846Q36337268-81B29EF9-1C15-453A-A3FA-8DD888220FF5Q36373902-1E224CE8-364F-4CC4-AFDA-3B1AA859354EQ36406701-81181135-D3CD-4FA2-8057-39B38C4EF415Q36777322-4B276FA3-668F-46FB-B2A5-26AC6DF6A2DDQ37078082-3C767D8B-283A-428D-A5DE-4A6D03B33CA4Q37255185-2F996694-098A-48A0-955B-8C25206CC033Q37307714-1EEF47C7-2DE9-4E86-97C4-F72C45C9CD95Q37337213-CDD35C8F-CCA4-4CF2-B05B-FC38BEBE1E18Q37337342-A567558C-5BEF-4F77-8EA1-4701C6A4B6C1Q37367335-6CA420E5-E66B-4CD3-8F47-EB4DB6BFEE49Q37624855-211B46D8-D7F4-476E-A727-67A68D71F99AQ37687962-1B147321-B6F5-432C-BEC6-41D76130F433Q37710417-BE2BD72D-9C08-4C05-8A0F-C6F1A1C5C97FQ37730165-9C7AFF44-12D5-4699-9C91-781F189E7B6CQ37760230-266C6295-39E7-46DD-9976-70D46CBC693EQ37793922-BA7024B0-3D27-409B-A6AA-93239D08D028Q37872610-B5DB0CB3-47F4-4168-8B98-1FC8A12AF66CQ37916658-43DC5A39-2447-4A77-BAA3-1DFB54A78828
P2860
Are quantum dots ready for in vivo imaging in human subjects?
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Are quantum dots ready for in vivo imaging in human subjects?
@ast
Are quantum dots ready for in vivo imaging in human subjects?
@en
Are quantum dots ready for in vivo imaging in human subjects?
@nl
type
label
Are quantum dots ready for in vivo imaging in human subjects?
@ast
Are quantum dots ready for in vivo imaging in human subjects?
@en
Are quantum dots ready for in vivo imaging in human subjects?
@nl
prefLabel
Are quantum dots ready for in vivo imaging in human subjects?
@ast
Are quantum dots ready for in vivo imaging in human subjects?
@en
Are quantum dots ready for in vivo imaging in human subjects?
@nl
P2093
P2860
P1476
Are quantum dots ready for in vivo imaging in human subjects?
@en
P2093
P2860
P2888
P304
P356
10.1007/S11671-007-9061-9
P577
2007-06-01T00:00:00Z
P5875
P6179
1013569524